Skip to main content

Table 1 Basic characteristics of patients

From: A nomogram for predicting cause-specific mortality among patients with cecal carcinoma: a study based on SEER database

Factors

Define

Train(N = 16,655)

Test(N = 7139)

All(N = 23,794)

Age

 < 40

37(0.22)

17(0.24)

54(0.23)

40 ~ 60

656(3.94)

277(3.88)

933(3.92)

60 ~ 

15,962(95.84)

6845(95.88)

22,807(95.85)

Marriage

Married

8862(53.21)

3777(52.91)

12,639(53.12)

Divorced

2452(14.72)

989(13.85)

3441(14.46)

Single

3548(21.3)

1546(21.66)

5094(21.41)

Other

1793(10.77)

827(11.58)

2620(11.01)

Race

White

13,563(81.44)

5828(81.64)

19,391(81.5)

Black

2121(12.73)

901(12.62)

3022(12.7)

Other

971(5.83)

410(5.74)

1381(5.8)

Sex

Female

9168(55.05)

3915(54.84)

13,083(54.98)

Male

7487(44.95)

3224(45.16)

10,711(45.02)

Behav

Behav1

10,993(66)

4676(65.5)

15,669(65.85)

Behav2

1880(11.29)

744(10.42)

2624(11.03)

Behav3

1648(9.89)

745(10.44)

2393(10.06)

Behav4

928(5.57)

455(6.37)

1383(5.81)

Other

1206(7.24)

519(7.27)

1725(7.25)

Grade

I

1311(7.87)

532(7.45)

1843(7.75)

II

11,230(67.43)

4808(67.35)

16,038(67.4)

III

3324(19.96)

1441(20.18)

4765(20.03)

IV

790(4.74)

358(5.01)

1148(4.82)

Stage

I

3879(23.29)

1590(22.27)

5469(22.98)

II

5018(30.13)

2179(30.52)

7197(30.25)

III

5342(32.07)

2320(32.5)

7662(32.2)

IV

2416(14.51)

1050(14.71)

3466(14.57)

Tstage

T1

1874(11.25)

763(10.69)

2637(11.08)

T2

2808(16.86)

1194(16.73)

4002(16.82)

T3

8313(49.91)

3618(50.68)

11,931(50.14)

T4

3660(21.98)

1564(21.91)

5224(21.96)

Nstage

N0

9211(55.3)

3915(54.84)

13,126(55.17)

N1

4012(24.09)

1772(24.82)

5784(24.31)

N2

3432(20.61)

1452(20.34)

4884(20.53)

Surgery

Surg1

13,275(79.71)

5751(80.56)

19,026(79.96)

Surg2

2777(16.67)

1122(15.72)

3899(16.39)

Surg3

191(1.15)

88(1.23)

279(1.17)

Surg4

412(2.47)

178(2.49)

590(2.48)

LNSur

4 ~ 

15,845(95.14)

6838(95.78)

22,683(95.33)

1 ~ 3

490(2.94)

172(2.41)

662(2.78)

None

320(1.92)

129(1.81)

449(1.89)

SurgOth

None

15,446(92.74)

6621(92.74)

22,067(92.74)

Yes

1209(7.26)

518(7.26)

1727(7.26)

Radiation

None

16,416(98.56)

7020(98.33)

23,436(98.5)

Yes

239(1.44)

119(1.67)

358(1.5)

Chemotherapy

None

5657(33.97)

2386(33.42)

8043(33.8)

Yes

10,998(66.03)

4753(66.58)

15,751(66.2)

Deposits

None

4339(26.05)

1892(26.5)

6231(26.19)

Yes

12,316(73.95)

5247(73.5)

17,563(73.81)

LnPositive

No

9179(55.11)

3954(55.39)

13,133(55.19)

1 ~ 3 Positive

3705(22.25)

1586(22.22)

5291(22.24)

4 ~ 6 Positive

1556(9.34)

676(9.47)

2232(9.38)

 > 7 Positive

2215(13.3)

923(12.93)

3138(13.19)

Bone

None

16,585(99.58)

7108(99.57)

23,693(99.58)

Yes

70(0.42)

31(0.43)

101(0.42)

Brain

None

16,636(99.89)

7133(99.92)

23,769(99.89)

Yes

19(0.11)

6(0.08)

25(0.11)

Liver

None

15,064(90.45)

6441(90.22)

21,505(90.38)

Yes

1591(9.55)

698(9.78)

2289(9.62)

Lung

None

16,314(97.95)

6973(97.67)

23,287(97.87)

Yes

341(2.05)

166(2.33)

507(2.13)

Size

 < 3 cm

9941(59.69)

4232(59.28)

14,173(59.57)

3 ~ 5 cm

2937(17.63)

1289(18.06)

4226(17.76)

 > 5 cm

3777(22.68)

1618(22.66)

5395(22.67)

  1. (1) Disease classification: Behav1-adenocarcinoma, NOS; Behav2-adenocarcinoma in tubulovillous adenoma; Behav3-mucinous adenocarcinoma; Behav4-adenocarcinoma in adenomatous poly; (2) Operation types: Sugery1-subtotal colectomy/hemicolectomy (partial colectomy but less than total colectomy, right or left colectomy (resection of left or right colon and partial transverse colon), or additional resection of other organs); Surgery2-partial colectomy but less than hemicolectomy or additional resection of adjacent organs; Surgery3 -no operation or tumor destruction, Surgery4-other extended operations